Furthermore, TUBA1C exhibited a positive correlation with almost all immunosuppressive, chemotactic, and chemotactic receptor genes in LGG, LIHC, and THCA, suggesting that TUBA1C influences tumour development through immune-related genes in these cancers. This evidence concerns the gene TUBA1C and neoplasm.